News: Biologics, Therapeutics and Devices

An innovative imaging technique enabled dramatically higher resolution structures than previous efforts.

A new antibody design blocks cytomegalovirus from hiding from the immune system and could lead to safer, more effective treatments for vulnerable patients.

The breakthrough could be used in a new vaccine or antibody therapy to fight mpox, the disease caused by the monkeypox virus.

The award recognizes Jason McLellan’s work to investigate how viruses infect our cells and to develop new treatments for infectious disease.

With support from the Cancer Prevention and Research Institute of Texas, molecular bioscientist Dima Kozakov joins UT.

Discovery brings us one step closer to vaccine and treatment for prevalent virus.

Biotech advances from UT’s new Deep Proteins group are changing the game with help from artificial intelligence.

Natural antimicrobials called microcins are produced by bacteria in the gut and show promise in fighting infection.

Protein large language models identify ways to make antibiotics better at targeting dangerous bacteria, without being toxic to humans.

The International Vaccine Institutes Bioscience Park MahnHoon Award recognizes his role in the development of several vaccines.